179 related articles for article (PubMed ID: 27377911)
1. Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.
Cho H; Cho Y; Cho EJ; Lee JH; Yu SJ; Oh KH; Lee K; Mustika S; Yoon JH; Kim YJ
Clin Mol Hepatol; 2016 Jun; 22(2):286-91. PubMed ID: 27377911
[TBL] [Abstract][Full Text] [Related]
2. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B].
Kim D; Lee J; Kim DH; Kang K; Suh SJ; Jung YK; Yim HJ
Korean J Gastroenterol; 2016 Dec; 68(6):317-320. PubMed ID: 28025475
[TBL] [Abstract][Full Text] [Related]
4. Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir.
Magalhães-Costa P; Matos L; Barreiro P; Chagas C
Rev Esp Enferm Dig; 2015 Jul; 107(8):512-4. PubMed ID: 26228957
[TBL] [Abstract][Full Text] [Related]
5. Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy: A Matched Case-Cohort Study.
Ha NB; Ku K; Ha NB; Chaung KT; Trinh HN; Nguyen MH
J Clin Gastroenterol; 2015; 49(10):873-7. PubMed ID: 25856383
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection.
Hwang HS; Park CW; Song MJ
Hepatology; 2015 Oct; 62(4):1318-20. PubMed ID: 25645518
[TBL] [Abstract][Full Text] [Related]
7. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients.
Tsai HJ; Chuang YW; Lee SW; Wu CY; Yeh HZ; Lee TY
Aliment Pharmacol Ther; 2018 Jun; 47(12):1673-1681. PubMed ID: 29696665
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.
Bunnell KL; Vibhakar S; Glowacki RC; Gallagher MA; Osei AM; Huhn G
Pharmacotherapy; 2016 Sep; 36(9):e148-53. PubMed ID: 27459733
[TBL] [Abstract][Full Text] [Related]
9. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study.
Lampertico P; Berg T; Buti M; Pathil A; Petersen J; Ryder SD; Zoulim F; Botros I; Flaherty JF; Jump B; Op den Brouw ML; van Troostenburg A; Ramroth H;
Aliment Pharmacol Ther; 2020 Aug; 52(3):500-512. PubMed ID: 32583915
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection.
Gracey DM; Snelling P; McKenzie P; Strasser SI
Antivir Ther; 2013; 18(7):945-8. PubMed ID: 23839869
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection.
Conti F; Vitale G; Cursaro C; Bernardi M; Andreone P
Ann Hepatol; 2016; 15(2):273-6. PubMed ID: 26845606
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
Park CH; Jung SW; Shin JW; Bae MA; Lee YI; Park YT; Chung HS; Park NH
Clin Mol Hepatol; 2016 Mar; 22(1):152-9. PubMed ID: 27044766
[TBL] [Abstract][Full Text] [Related]
13. Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients.
Wang HM; Hung CH; Lee CM; Lu SN; Wang JH; Yen YH; Kee KM; Chang KC; Tseng PL; Hu TH; Chen CH
J Gastroenterol Hepatol; 2016 Jul; 31(7):1307-14. PubMed ID: 26758501
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease.
Tsai HJ; Chuang YW; Yang SS; Chang YZ; Chang HR; Lee TY
J Viral Hepat; 2021 Nov; 28(11):1579-1586. PubMed ID: 34464999
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling.
Tien C; Xu JJ; Chan LS; Chang M; Lim C; Lee S; Huh B; Shinada S; Bae HS; Fong TL
Dig Dis Sci; 2015 Feb; 60(2):566-72. PubMed ID: 25239496
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation.
Hung CH; Hu TH; Lu SN; Lee CM; Chen CH; Kee KM; Wang JH; Tsai MC; Kuo YH; Chang KC; Chiu YC; Chen CH
Antimicrob Agents Chemother; 2015; 59(6):3168-73. PubMed ID: 25779569
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.
Hsu YC; Wei MT; Nguyen MH
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):999-1008. PubMed ID: 28965428
[TBL] [Abstract][Full Text] [Related]
18. Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.
Ahn HJ; Song MJ; Jang JW; Bae SH; Choi JY; Yoon SK
PLoS One; 2017; 12(1):e0170362. PubMed ID: 28114428
[TBL] [Abstract][Full Text] [Related]
19. Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.
Viganò M; Brocchieri A; Spinetti A; Zaltron S; Mangia G; Facchetti F; Fugazza A; Castelli F; Colombo M; Lampertico P
J Clin Virol; 2014 Dec; 61(4):600-3. PubMed ID: 25453573
[TBL] [Abstract][Full Text] [Related]
20. Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir-induced renal dysfunction.
Chotiyaputta W; Poosanasuwansri K; Kiattisunthorn K; Chainuvati S; Tanwandee T
J Viral Hepat; 2021 Feb; 28(2):364-372. PubMed ID: 33047455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
